ReviewFrontiers in surgery2022

Short-Course or Total Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic Cancer - Current Status and Future Perspectives.

Knut Jørgen LaboriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.